RxDoctor Payments Data

Basavalinga Talur Matadha, MD

Hospitalist · Portsmouth, VANPI 1639378839

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 39 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Johnson & Johnson accounts for 72.2% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2023 at $595 and has fallen 94.9% since, to $30 in 2025. Among hospitalist clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,504in general payments, 2019–2025

Across 39 payments — averaging $38.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$1K
  • Boehringer Ingelheim$143
  • Portola Pharmaceuticals, LLC$124
  • Amgen$64
  • AbbVie$33
  • Ceribell, Inc.$30
  • plus $23 from 1 others

What the payments were for

  • Food & beverage$1,504100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,504 in reported general payments places this provider in the 95th percentile of 539 hospitalist providers in Virginia.

See all hospitalist providers in Virginia

Medicare billing

Part B allowed, 2024
$77,513
Medicare patients
303
Services billed
837

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban13$9,020
Levetiracetam14$323
Pantoprazole Sodium40$208
CefuroximeCefuroxime Axetil17$203
Metoprolol Succinate25$121
Carvedilol14$104
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav15$92
Levofloxacin16$88
Atorvastatin Calcium26$87
Hydralazine Hcl17$78
Amlodipine Besylate30$67
ClopidogrelClopidogrel Bisulfate19$55
Losartan Potassium12$53
Doxycycline Hyclate11$51
Tamsulosin Hcl11$48

Paid to pharmacies, not to this prescriber.

Other hospitalist in Portsmouth

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →